Two‐year trajectories of COVID‐19 symptoms and their association with illness perception: A prospective cohort study in Amsterdam, the Netherlands
Rattachement africain : nl, ca. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background: We used data from a prospective cohort to explore 2-year trajectories of 'long COVID' (persistent symptoms after SARS-CoV-2 infection) and their association with illness perception. Methods: RECoVERED participants (adults; prospectively enrolled following laboratory-confirmed SARS-CoV-2 infection, May 2020-June 2021) completed symptom questionnaires at months 2-12, 18 and 24, and the Brief Illness Perception Questionnaire (B-IPQ) at months 1, 6 and 12. Using group-based trajectory models (GBTM), we modelled symptoms (mean total numbers and proportion with four specific complaints), including age, sex, BMI and timing of infection as covariates. In a multivariable linear mixed-effects model, we assessed the association between symptom trajectories and repeated B-IPQ scores. Results: Among 292 participants (42% female; median age 51 [IQR = 36-62]), four trajectories were identified, ranging from Trajectory 4 (8.9%; 6 + symptoms) to Trajectory 1 (24.8%; no symptoms). The occurrence of fatigue and myalgia increased among 23% and 12% of participants, respectively. Individuals in Trajectory 4 experienced more negative adjusted B-IPQ scores over time than those in Trajectories 1-3. Conclusions: We observed little fluctuation in the total number of symptoms, but individual symptoms may develop as others resolve. Reporting a greater number of symptoms was congruent with more negative illness perception over time.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Two‐year trajectories of COVID‐19 symptoms and their association with illness perception: A prospective cohort study in Amsterdam, the Netherlands
- Date Crossref
- 01/10/2023
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
GGD Amsterdam pays non établi dans la noticeÉtablissement de santé
-
Amsterdam University Medical Centers pays non établi dans la noticeÉtablissement de santé
-
Institute of Infection and Immunity pays non établi dans la noticeStructure de recherche
-
University of Amsterdam Department of Medical Microbiology & pays non établi dans la noticeUniversité ou école supérieure
-
National Institute for Public Health and the Environment Center for Infectious Disease Control (LCI) pays non établi dans la noticeStructure de recherche
-
Stichting HIV Monitoring pays non établi dans la noticeInstitution
-
Department of Infectious Diseases Public Health Service of Amsterdam Amsterdam the Netherlands pays non établi dans la noticeInstitution
GGD Amsterdam, Amsterdam University Medical Centers et Institute of Infection and Immunity, avec 4 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.